Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Bringing it to an End!
View:
Post by FarmerBetsy on Jul 10, 2023 10:52am

Bringing it to an End!

They know what they are doing!  Delisting from the tsx to save money find me a fool who believes that?
Comment by retiredcop on Jul 10, 2023 11:45am
More polite then saying get rid of the TSX so we can make some money on the US side . The TSx has never been able to support this company and if its tied into nasdaq then they cant get traction. It was pointed out to me by a long time investor, for months CIBC has been dragging the stock prices down on the TSx,,, well guess who is the biggest buyer today on the TSX ... yes I know ...it could be ...more  
Comment by M101 on Jul 10, 2023 2:24pm
RC, care to elaborate on this? "The TSx has never been able to support this company and if its tied into nasdaq then they cant get traction." 
Comment by Alex1726 on Jul 10, 2023 7:27pm
Full of sh....it as usual , Bellus Health was listed on nasdaq and on the tsx and that did not prevent GSK to offer $2B for Bellus. A nasdaq listing makes it easier for new equities issues. Companies are rewarded when they create value for shareholders no matter what market they're listed to. When you sit on your steak thinking a US firm or a big player will create for you the best conditions ...more  
Comment by Alex1726 on Jul 10, 2023 7:42pm
A market cap of not even $30M U.S and they pretend to own the best in class medication for AD. Can someone explain why any big pharma agree? After all your market cap can increase BIG TIME ($15B) There is no way to find an agreement between $30M and $15B???? They're all crooks , they FIRST serve themselves. 
Comment by M101 on Jul 10, 2023 12:21pm
Apparently a lot of people believe it, enough to exit at a loss, because it says they can't find any partners and aren't prepared to cut their pay packages.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities